Pallavi Chiprikar

Pallavi Chiprikar

Auto-generated profile, based on publicly available information

Pallavi Chiprikar

Department of Basic Sciences, School of Sciences and Humanities, SR University, Warangal, India 506371

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

31 July 2025 in Drug Metabolism Letters
Verified
Journal Article
Closed access
UPUmeshkumar Patel
Umeshkumar Patel
VMVinayak Mastiholimath
Vinayak Mastiholimath
PCPallavi Chiprikar
Pallavi Chiprikar
Introduction: The antifungal drug bifonazole, a substituted imidazole, exhibits broadspectrum in vitro action against Gram-positive bacteria, yeasts, moulds, dermatophytes, and dimorphic fungi. Method: The analysis was carried out using a C18 reversed-phase column (250 mm × 4.6 mm, 5 µm particle size) maintained at a constant temperature of 25°C. Methanol and 0.1% trifluoroacetic acid were utilized as the mobile phase. Detection was performed at 256 nm with a UV detector, and quantification was achieved using the standard method. The method validation was carried out for various parameters as per ICH guidelines. The developed eco-friendly HPLC method was employed to assess the vesicle size and entrapment efficiency of the transethosomes. The greenness assessment tool was applied to assess the environmental sustainability of the proposed HPLC method. Result: The retention time was under 5 minutes, confirming the method';s appropriateness for routine analysis. Linearity was observed in the concentration range of 5 to 25µg/ml, LOD and LOD were 2µg/ml and 8µg/ml respectively. Intraday and interday precision were within ICH limits (<2). The method was successfully used to analyse vesicle size (178nm) and entrapment efficiency (77.6±0.72%.) of the nanoformulation. The greenness assessment tool yielded a value of 0.71. Discussion: The developed method is both analytically sound and eco-friendly, making a significant improvement in the estimation of bifonazole. The developed method';s LOD and LOQ values were sufficiently low to facilitate the detection and measurement of bifonazole in pharmaceutical formulations frequently utilized in research applications, thereby supporting its potential utility in analytical and research settings. Conclusion:: Overall, this green, eco-friendly HPLC method is well-suited for routine analysis of bifonazole, demonstrating excellent cost-effectiveness, sensitivity, precision, and robustness.

1 September 2024 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
PCPallavi Chiprikar
Pallavi Chiprikar
VMVinayak Mastiholimath
Vinayak Mastiholimath
PBPrakash Biradar
Prakash Biradar
NSNisha Shirkoli
Nisha Shirkoli
Background: Cariprazine (CPZ) is a third-generation antipsychotic medication that has been approved for treating schizophrenia. This study aimed to develop a cariprazine-loaded nanostructured lipid carrier (CPZ-NLCs) to prevent first-pass metabolism and improve bioavailability and site-specific delivery from nose to the brain. Methods: The CPZ-NLCs were prepared using melt emulsification. The formulation was optimized using the Box–Behnken design (BBD); where the influence of independent variables on critical quality attributes, such as particle size and entrapment efficiency was studied. Results: The optimized batch (F6) had a particle size of 173.3 ± 0.6 nm and an entrapment efficiency of 96.1 ± 0.57%, respectively. The in vitro release showed >96% release of CPZ from NLC within 30 min. The optimized formulation's ex vivo studies revealed significantly increased CPZ permeability (>75%) in sheep nasal mucosa compared to the CPZ suspension (~26%). The ciliotoxicity study of the nasal mucosa revealed that the CPZ-NLC formulation did not affect the nasal epithelium. The intranasal administration of the formulation achieved 76.14±6.23 μg/ml concentration in the brain which was significantly higher than the oral CPZ suspension administration (30.46±7.24 μg/ml). The developed formulation was stable for 3 months. Conclusion: The study concluded that the developed CPZ-NLC could significantly improve the bioavailability with quick delivery to the brain.

1 June 2026 in Research Square
Verified
Preprint
Open access
PDF file
RDRahul Dhaigude
Rahul Dhaigude
SSSonal Solanki
Sonal Solanki
NSNikunj Solanki
Nikunj Solanki
STSreekanth Thota
Sreekanth Thota
PSPranita Santosh Shankaratti
Pranita Santosh Shankaratti
PCPallavi Chiprikar
Pallavi Chiprikar
Quality by Design (QbD) studies generate structured formulation datasets, but response surface models may not fully describe nonlinear or response-specific behavior in nanoparticle systems. This study reanalyzed a published silymarin-loaded lecithin/chitosan nanoparticle QbD dataset to determine whether independent explainable machine learning could add predictive and interpretive value to conventional QbD outputs. Twenty-nine formulation runs, comprising six formulation/process inputs and three critical quality attributes—particle size, polydispersity index (PDI), and entrapment efficiency—were extracted and modeled. A model-zoo of 105 regression variants per response was evaluated using leave-one-out cross-validation, followed by optimized-checkpoint comparison with reported QbD/RSM predictions, permutation feature importance, partial dependence analysis, and predictive design space mapping. Model performance was response dependent: XGBoost provided the best global particle-size prediction (R² = 0.926; RMSE = 27.52 nm), Extra Trees was best for PDI (R² = 0.695; RMSE = 0.0379), and distance-weighted KNN was best for entrapment efficiency (R² = 0.938; RMSE = 1.72%). At the optimized checkpoint, Gaussian Process regression predicted particle size with lower error than RSM (0.789 vs. 8.804 nm), and checkpoint-compatible Random Forest predicted PDI more closely than RSM (0.0004 vs. 0.032 absolute error), whereas RSM remained slightly closer for entrapment efficiency. Explainable AI identified lecithin:chitosan ratio and drug amount as recurring formulation drivers, while the predicted acceptable region was concentrated within intermediate formulation ranges. These findings support explainable machine learning as a complementary layer for QbD-based nanoparticle development rather than as a replacement for response surface modeling.

28 December 2023 in INDIAN DRUGS
Verified
Journal Article
Closed access
PCPallavi Chiprikar
Pallavi Chiprikar
NRNisharani Ranpise
Nisharani Ranpise
Acyclovir has a 10-30 % oral bioavailability with a half-life of 2-3 h. Acyclovir mainly gets solubilized in acidic conditions, and its absorption is found in the upper GIT. The primary aim of this research work was to formulate gastroretentive dosage form of acyclovir that can float on gastric content. The polymer used was sodium alginate, while the floating agent was calcium carbonate. The dependent variables of drug release, floating lag time and viscosity were significantly impacted by sodium alginate and CaCO3 concentrations. To assess the desired release pattern, a dissolution was performed in 0.1 N HCl at 50 rpm. Shear-thinning behaviour, instant gelation, 99.2 % drug release at 12 h, and instant floating ability greater than 12 h in 0.1 N HCl were all observed in the suspension. Consequently, a sustained-release floating dosage form for acyclovir, with a duration of 12 h, was successfully developed.